These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2844304)

  • 1. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
    Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A; Rousset M; Laburthe M
    Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29).
    Muller JM; Luis J; Fantini J; Abadie B; Giannellini F; Marvaldi J; Pichon J
    Eur J Biochem; 1985 Sep; 151(2):411-7. PubMed ID: 2992966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
    Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM
    Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
    McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29.
    Turner JT; Jones SB; Bylund DB
    Peptides; 1986; 7(5):849-54. PubMed ID: 3025826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallel activation of cyclic AMP phosphodiesterase and cyclic AMP-dependent protein kinase in two human gut adenocarcinoma cells (HT 29 and HRT 18) in culture, by vasoactive intestinal peptide (VIP) and other effectors activating the cyclic AMP system.
    Mangeat P; Marvaldi J; Ahmed OA; Marchis-Mouren G
    Regul Pept; 1981 Mar; 1(6):397-414. PubMed ID: 6262879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts.
    Wood CL; O'Dorisio MS
    J Biol Chem; 1985 Jan; 260(2):1243-7. PubMed ID: 2981838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective photolabeling of high and low affinity binding sites for vasoactive intestinal peptide (VIP): evidence for two classes of covalent VIP-receptor complexes in intestinal cell membranes.
    Robichon A; Marie JC
    Endocrinology; 1987 Mar; 120(3):978-85. PubMed ID: 3026793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
    Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
    el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J
    J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
    J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
    Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J
    Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined ultrastructural and biochemical study of cellular processing of vasoactive intestinal peptide and its receptors in human colonic carcinoma cells in culture.
    Hejblum G; Gali P; Boissard C; Astesano A; Marie JC; Anteunis A; Hui Bon Hoa D; Rosselin G
    Cancer Res; 1988 Nov; 48(21):6201-10. PubMed ID: 2844402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rat liver vasoactive intestinal peptide binding site. Molecular characterization by covalent cross-linking and evidence for differences from the intestinal receptor.
    Couvineau A; Laburthe M
    Biochem J; 1985 Jan; 225(2):473-9. PubMed ID: 3977841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VIP receptors and control of short circuit current in the human intestinal clonal cell line Cl.19A.
    Rouyer-Fessard C; Augeron C; Grasset E; Maoret JJ; Laboisse CL; Laburthe M
    Experientia; 1989 Dec; 45(11-12):1102-5. PubMed ID: 2557231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level.
    Laburthe M; Rousset M; Rouyer-Fessard C; Couvineau A; Chantret I; Chevalier G; Zweibaum A
    J Biol Chem; 1987 Jul; 262(21):10180-4. PubMed ID: 3038870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.